参考文献/References:
[1]《中国心血管健康与疾病报告2020》编写组. 《中国心血管健康与疾病报告2020》要点解读[J]. 中国心血管杂志,2021,26(3):209-218.
[2]Hirshkowitz M,Whiton K,Albert SM,et al. National Sleep Foundation’s sleep time duration recommendations:methodology and results summary[J]. Sleep Health,2015,1(1):40-43.
[3]Wang D,Li W,Cui X,et al. Sleep duration and risk of coronary heart disease:a systematic review and meta-analysis of prospective cohort studies[J]. Int J Cardiol,2016,219:231-239.
[4]Kim JH,Hayek SS,Ko YA,et al. Sleep duration and mortality in patients with coronary artery disease[J]. Am J Cardiol,2019,123(6):874-881.
[5]Daghlas I,Dashti HS,Lane J,et al. Sleep duration and myocardial infarction[J]. J Am Coll Cardiol,2019,74(10):1304-1314.
[6]Li H,Ren Y,Wu Y,et al. Correlation between sleep duration and hypertension:a dose-response meta-analysis[J]. J Hum Hypertens,2019,33(3):218-228.
[7]Wang L,Hu Y,Wang X,et al. The association between sleep duration and hypertension:a meta and study sequential analysis[J]. J Hum Hypertens,2021,35(7):621-626.
[8]Jiang W,Hu C,Li F,et al. Association between sleep duration and high blood pressure in adolescents:a systematic review and meta-analysis[J]. Ann Hum Biol,2018,45(6-8):457-462.
[9]Sun J,Wang M,Yang L,et al. Sleep duration and cardiovascular risk factors in children and adolescents:a systematic review[J]. Sleep Med Rev,2020,53:101338.
[10]Li X,Zhou T,Ma H,et al. Healthy sleep patterns and risk of incident arrhythmias[J]. J Am Coll Cardiol,2021,78(12):1197-1207.
[11]Genuardi MV,Ogilvie RP,Saand AR,et al. Association of short sleep duration and atrial fibrillation[J]. Chest,2019,156(3):544-552.
[12]Arafa A,Kokubo Y,Shimamoto K,et al. Sleep duration and atrial fibrillation risk in the context of predictive, preventive, and personalized medicine:the Suita Study and meta-analysis of prospective cohort studies[J]. EPMA J,2022,13(1):77-86.
[13]Zhao J,Yang F,Zhuo C,et al. Association of sleep duration with atrial fibrillation and heart failure:a Mendelian randomization analysis[J]. Front Genet,2021,12:583658.
[14]Wannamethee SG,Papacosta O,Lennon L,et al. Self-reported sleep duration,napping,and incident heart failure:prospective associations in the British regional heart study[J]. J Am Geriatr Soc,2016,64(9):1845-1850.
[15]Bughin F,Jaussent I,Ayoub B,et al. Prognostic impact of sleep patterns and related-drugs in patients with heart failure[J]. J Clin Med,2021,10(22):5387.
[16]Wang H,Sun J,Sun M,et al. Relationship of sleep duration with the risk of stroke incidence and stroke mortality:an updated systematic review and dose-response meta-analysis of prospective cohort studies[J]. Sleep Med,2022,90:267-278.
[17]Gottlieb E,Landau E,Baxter H,et al. The bidirectional impact of sleep and circadian rhythm dysfunction in human ischaemic stroke:a systematic review[J]. Sleep Med Rev,2019,45:54-69.
[18]Titova OE,Micha?lsson K,Larsson SC. Sleep duration and stroke:prospective cohort study and Mendelian randomization analysis[J]. Stroke,2020,51(11):3279-3285.
[19]Holmer BJ,Lapierre SS,Jake-Schoffman DE,et al. Effects of sleep deprivation on endothelial function in adult humans:a systematic review[J]. Geroscience,2021,43(1):137-158.
[20]Liu H,Chen A. Roles of sleep deprivation in cardiovascular dysfunctions[J]. Life Sci,2019,219:231-237.
[21]McAlpine CS,Kiss MG,Rattik S,et al. Sleep modulates haematopoiesis and protects against atherosclerosis[J]. Nature,2019,566(7744):383-387.
[22]Ai S,Zhang J,Zhao G,et al. Causal associations of short and long sleep durations with 12 cardiovascular diseases:linear and nonlinear Mendelian randomization analyses in UK Biobank[J]. Eur Heart J,2021,42(34):3349-3357.
[23]Kwok CS,Kontopantelis E,Kuligowski G,et al. Self-reported sleep duration and quality and cardiovascular disease and mortality:a dose-response meta-analysis[J]. J Am Heart Assoc,2018,7(15):e008552.
[24]Lee HW,Yoon HS,Yang JJ,et al. Association of sleep duration and quality with elevated hs-CRP among healthy Korean adults[J]. PLoS One,2020,15(8):e0238053.
[25] He L,Yang N,Ping F,et al. Long sleep duration is associated with increased high-sensitivity C-reactive protein:a nationwide study on Chinese population[J]. Diabetes Metab Syndr Obes,2020,13:4423-4434.
[26]Koosha P,Roohafza H,Sarrafzadegan N,et al. High sensitivity C-reactive protein predictive value for cardiovascular disease:a nested case control from Isfahan Cohort Study(ICS)[J]. Glob Heart,2020,15(1):3.
[27]Matsubayashi H,Nagai M,Dote K,et al. Long sleep duration and cardiovascular disease:associations with arterial stiffness and blood pressure variability[J]. J Clin Hypertens(Greenwich),2021,23(3):496-503.
[28]Crnko S,Du Pré BC,Sluijter JPG et al. Circadian rhythms and the molecular clock in cardiovascular biology and disease[J]. Nat Rev Cardiol,2019,16(7):437-447.
[29]Chellappa SL,Vujovic N,Williams JS,et al. Impact of circadian disruption on cardiovascular function and disease[J]. Trends Endocrinol Metab,2019,30(10):767-779.
[30]Gentry NW,Ashbrook LH,Fu YH,et al. Human circadian variations[J]. J Clin Invest,2021,131(16):e148282.
[31]Wang L,Li J,Du Y,et al. The relationship between sleep onset time and cardiometabolic biomarkers in Chinese communities:a cross-sectional study[J]. BMC Public Health,2020,20(1):374.
[32]Fan Y,Wu Y,Peng Y,et al. Sleeping late increases the risk of myocardial infarction in the middle-aged and older populations[J]. Front Cardiovasc Med,2021,8:709468.
[33]Yan B,Li R,Li J,et al. Sleep timing may predict congestive heart failure:a community-based cohort study[J]. J Am Heart Assoc,2021,10(6):e018385.
[34]Cheng M,He H,Wang D,et al. Shift work and ischaemic heart disease:meta-analysis and dose-response relationship[J]. Occup Med(Lond),2019,69(3):182-188.
[35]Wang N,Sun Y,Zhang H,et al. Long-term night shift work is associated with the risk of atrial fibrillation and coronary heart disease[J]. Eur Heart J,2021,42(40):4180-4188.
[36]Su F,Huang D,Wang H,et al. Associations of shift work and night work with risk of all-cause,cardiovascular and cancer mortality:a meta-analysis of cohort studies[J]. Sleep Med,2021,86:90-98.
[37]Gamboa Madeira S,Fernandes C,Paiva T,et al. The impact of different types of shift work on blood pressure and hypertension:a systematic review and meta-analysis[J]. Int J Environ Res Public Health,2021,18(13):6738.
[38]Morris CJ,Purvis TE,Hu K,et al. Circadian misalignment increases cardiovascular disease risk factors in humans[J]. Proc Natl Acad Sci U S A,2016,113(10):E1402-E1411.
[39]Morris CJ,Purvis TE,Mistretta J,et al. Circadian misalignment increases C-reactive protein and blood pressure in chronic shift workers[J]. J Biol Rhythms,2017,32(2):154-164.
[40]Baron KG,Duffecy J,Richardson D,et al. Technology assisted behavior intervention to extend sleep among adults with short sleep duration and prehypertension/stage 1 hypertension:a randomized pilot feasibility study[J]. J Clin Sleep Med,2019,15(11):1587-1597.
[41]杨浩其. 改善睡眠对成人慢性心力衰竭患者心率变异性和心功能的影响分析[J]. 世界睡眠医学杂志,2020,7(5):781-782.
[42]Hannemann J,Laing A,Middleton B,et al. Light therapy improves diurnal blood pressure control in night shift workers via reduction of catecholamines:the EuRhythDia study[J]. J Hypertens,2021,39(8):1678-1688.
[43]Hadi A,Ghaedi E,Moradi S,et al. Effects of melatonin supplementation on blood pressure:a systematic review and meta-analysis of randomized controlled trials[J]. Horm Metab Res,2019,51(3):157-164.
[44]Hoseini SG,Heshmat-Ghahdarijani K,Khosrawi S,et al. Effect of melatonin supplementation on endothelial function in heart failure with reduced ejection fraction:a randomized,double-blinded clinical trial[J]. Clin Cardiol,2021,44(9):1263-1271.
相似文献/References:
[1]白春兰,张军.正五聚蛋白-3:新型心血管病炎性标志物[J].心血管病学进展,2016,(1):87.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.023]
BAI Chunlan,ZHANG Jun.Pentraxin-3: A Novel Inflammation Biomarker for Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2016,(1):87.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.023]
[2]任茂佳,贺文帅,张琪,等.围绝经期对心血管疾病相关危险因素的影响[J].心血管病学进展,2019,(6):911.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.018]
REN Maojia,HE Wenshuai,ZHANG Qi,et al.Effects of Perimenopause on Cardiovascular Risk Factors[J].Advances in Cardiovascular Diseases,2019,(1):911.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.018]
[3]尹琳 黄从新.JP2蛋白和心血管疾病的研究进展[J].心血管病学进展,2019,(7):1004.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.010]
YIN Lin HUANG Congxin.Research Progress of JP2 Protein and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2019,(1):1004.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.010]
[4]朱峰 汪汉 蔡琳.抗体与心血管疾病[J].心血管病学进展,2019,(7):1007.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.011]
ZHU FengWANG HanCAI Lin.Antibodies and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2019,(1):1007.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.011]
[5]邱明仙 王正龙 许官学.心肌肌球蛋白结合蛋白-C磷酸化与心血管疾病关系的研究进展[J].心血管病学进展,2019,(7):1015.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.013]
QIU MingxianWANG ZhenglongXU Guanxue.Research Progress of the Relationship Between Cardiac Myosin Binding Protein-C and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2019,(1):1015.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.013]
[6]姬楠楠 杨晓静 谢勇.单核细胞/高密度脂蛋白比值与心血管疾病的研究进展[J].心血管病学进展,2019,(7):1019.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.014]
JI Nannan YANG Xiaojing XIE Yong.Monocyte/High-density Lipoprotein Ratio and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2019,(1):1019.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.014]
[7]渠海贤 李涛 程流泉.人工智能在心脏磁共振成像中的应用进展[J].心血管病学进展,2019,(5):659.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.001]
[8]侯冬华 郝丽荣.长正五聚蛋白3在动脉粥样硬化和心血管疾病中作用研究的新进展[J].心血管病学进展,2019,(5):805.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.035]
HOU Donghua H AO Lirong.The Study of Atherosclerosis and Cardiovascular Diseases with Pentapycin 3[J].Advances in Cardiovascular Diseases,2019,(1):805.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.035]
[9]张维 张恒 康品方.外泌体在心血管疾病中的研究进展[J].心血管病学进展,2019,(5):818.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.038]
Zhang WeiKang Pinfang.Exosome in Cardiovascular Diseases[J].Advances in Cardiovascular Diseases,2019,(1):818.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.038]
[10]韦莹 刘书旺 李蕾 崔鸣.生长分化因子-15在心房颤动中的研究进展[J].心血管病学进展,2019,(8):1073.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.001]
WEI Ying,LIU Shuwang,LI Lei,et al.Growth Differentiation Factor-15 in Development of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2019,(1):1073.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.001]